Webinars are free and open to the public. You do not need to be an ASA member to attend.
Includes one complimentary Continuing Education (CE) credit.
To request speech-to-text captioning during this event, please contact us.
Learn how managing blood pressure can reduce the risk of cognitive decline and dementia and hear recommendations for applying the latest science in clinical practice and community education.
Participants in this webinar will be able to:
- List six or more modifiable risk factors for dementia.
- Summarize the link between hypertension and dementia.
- Identify effective interventions and strategies to address hypertension, with a special focus on adults ages 45 and older.
- Identify special considerations for high-risk populations.
Mitchell Elkind, MD, MS, is a tenured professor of Neurology and Epidemiology at Columbia University Irving Medical Center, and chief of the Division of Neurology Clinical Outcomes Research and Population Sciences in the Neurology Department. Dr Elkind’s research focuses on stroke prevention, inflammatory and infectious biomarkers in stroke risk prediction, atrial cardiopathy, immune therapy for acute stroke and vascular causes of cognitive aging. He is the principal investigator of several independent investigator awards from NIH/NINDS, including the ARCADIA trial of apixaban vs aspirin for atrial cardiopathy in cryptogenic stroke; the Northern Manhattan Study (NOMAS), an epidemiological study of stroke risk factors; the Neuroprotection with Statin Therapy for Acute Recovery Trial (NeuSTART), a clinical trial evaluating short-term high-dose statin therapy in acute stroke; and the Levels of Inflammatory Markers in Treatment of Stroke (LIMITS) study.